DESRESFRIOL-DX Trademark

Trademark Overview


On Monday, February 20, 2023, a trademark application was filed for DESRESFRIOL-DX with the United States Patent and Trademark Office. The USPTO has given the DESRESFRIOL-DX trademark a serial number of 97802953. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, November 27, 2023. This trademark is owned by Go 4 it LLC. The DESRESFRIOL-DX trademark is filed in the Pharmaceutical Products category with the following description:

Cold sore treatment preparations; Cough treatment preparations; Pain relief medication
desresfriol-dx

General Information


Serial Number97802953
Word MarkDESRESFRIOL-DX
Filing DateMonday, February 20, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, November 27, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCold sore treatment preparations; Cough treatment preparations; Pain relief medication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGo 4 it LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 92101

Trademark Events


Event DateEvent Description
Monday, November 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, November 27, 2023LETTER OF SUSPENSION E-MAILED
Monday, November 27, 2023SUSPENSION LETTER WRITTEN
Thursday, November 16, 2023ASSIGNED TO EXAMINER
Friday, March 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 23, 2023NEW APPLICATION ENTERED